Soluble Suppression of Tumorigenicity 2 is Directly Correlated with Glycated Hemoglobin in Individuals with an Average glycemia in the Normal/Prediabetes Range
Amal Hasan,1 Waleed Aldhahi2,3 1Department of Immunology and Microbiology, Dasman Diabetes Institute, Kuwait City, Kuwait; 2Medical Division, Dasman Diabetes Institute, Kuwait City, Kuwait; 3Department of Medicine, Mubarak Al-Kabeer Hospital, Kuwait City, KuwaitCorrespondence: Amal Hasan Email amal....
Main Authors: | Hasan A, Aldhahi W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-08-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/soluble-suppression-of-tumorigenicity-2-is-directly-correlated-with-gl-peer-reviewed-article-DMSO |
Similar Items
-
Soluble suppression of tumorigenicity 2 associated with major adverse cardiac events in children with myocarditis
by: Tongtong Shi, et al.
Published: (2024-05-01) -
Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
by: Dong-Hui Huang, et al.
Published: (2016-01-01) -
Prediabetes screening: Questionable benefits in the golden years
by: Dimitrios Tsilingiris, et al.
Published: (2021-06-01) -
Optimal glycated hemoglobin A1c value for prediabetes and diabetes in patients with pancreatic diseases
by: Guanhua Chen, et al.
Published: (2023-07-01) -
Predictive value of soluble suppression of tumorigenicity 2 in atrial fibrillation: a systematic review and meta-analysis
by: Pengfei Chen, et al.
Published: (2024-01-01)